Santhera

Developer of drugs for treating mitochondrial and neuromuscular diseases

placeLiestal, Basel Landschaft, Switzerland calendar_todayFounded 2004 groups73 employees language santhera.com

Social engagement

Social engagement: 25.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record.

Investor typeCountShare
Private equity117%
Other / undisclosed583%

Recent activity

2 Jun 2026
Recognition
Nxera Pharma Co., Ltd.
20 May 2026
Event
International Conference on Duchenne and Becker Muscular Dystrophy
30 Apr 2026
Leadership hire
Board of Directors
Coming soon